Cargando…
A highly conserved epitope on the spike protein of infectious bronchitis virus
The predicted amino acid sequence and secondary structures of S1 of the spike protein (S) of infectious bronchitis viral (IBV) strains from Europe, the U.S.A., and Japan were compared. An antigenic determinant that was highly conserved in both the primary amino acid sequence and secondary structure...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087072/ https://www.ncbi.nlm.nih.gov/pubmed/8572941 http://dx.doi.org/10.1007/BF01323240 |
_version_ | 1783509260375687168 |
---|---|
author | Wang, L. Parr, R. L. King, D. J. Collisson, E. W. |
author_facet | Wang, L. Parr, R. L. King, D. J. Collisson, E. W. |
author_sort | Wang, L. |
collection | PubMed |
description | The predicted amino acid sequence and secondary structures of S1 of the spike protein (S) of infectious bronchitis viral (IBV) strains from Europe, the U.S.A., and Japan were compared. An antigenic determinant that was highly conserved in both the primary amino acid sequence and secondary structure of all strains was identified between amino acid positions 240 to 255. A synthesized peptide corresponding to this region was found to react with all polyclonal antisera examined from various IBV strains and with one monoclonal antibody (MAb), 9B1B6, out of nine known to react with the S of Gray. The specificity of the interaction with MAb 9B1B6 was confirmed by competitive ELISA using bound and unbound peptide. Interestingly, the previously described epitope for 9B1B6 had been characterized as cross-reactive with several strains of IBV, as conformation-independent but reacting only with intact whole S, and as associated with the functional integrity of other epitopes, including neutralizing epitopes on the S protein. The apparent critical functional and structural nature of this highly immunogenic determinant suggests a potential contribution in developing protective, cross-reactive subunit vaccines to IBV. |
format | Online Article Text |
id | pubmed-7087072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-70870722020-03-23 A highly conserved epitope on the spike protein of infectious bronchitis virus Wang, L. Parr, R. L. King, D. J. Collisson, E. W. Arch Virol Original Papers The predicted amino acid sequence and secondary structures of S1 of the spike protein (S) of infectious bronchitis viral (IBV) strains from Europe, the U.S.A., and Japan were compared. An antigenic determinant that was highly conserved in both the primary amino acid sequence and secondary structure of all strains was identified between amino acid positions 240 to 255. A synthesized peptide corresponding to this region was found to react with all polyclonal antisera examined from various IBV strains and with one monoclonal antibody (MAb), 9B1B6, out of nine known to react with the S of Gray. The specificity of the interaction with MAb 9B1B6 was confirmed by competitive ELISA using bound and unbound peptide. Interestingly, the previously described epitope for 9B1B6 had been characterized as cross-reactive with several strains of IBV, as conformation-independent but reacting only with intact whole S, and as associated with the functional integrity of other epitopes, including neutralizing epitopes on the S protein. The apparent critical functional and structural nature of this highly immunogenic determinant suggests a potential contribution in developing protective, cross-reactive subunit vaccines to IBV. Springer-Verlag 1995 /pmc/articles/PMC7087072/ /pubmed/8572941 http://dx.doi.org/10.1007/BF01323240 Text en © Springer-Verlag 1995 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Papers Wang, L. Parr, R. L. King, D. J. Collisson, E. W. A highly conserved epitope on the spike protein of infectious bronchitis virus |
title | A highly conserved epitope on the spike protein of infectious bronchitis virus |
title_full | A highly conserved epitope on the spike protein of infectious bronchitis virus |
title_fullStr | A highly conserved epitope on the spike protein of infectious bronchitis virus |
title_full_unstemmed | A highly conserved epitope on the spike protein of infectious bronchitis virus |
title_short | A highly conserved epitope on the spike protein of infectious bronchitis virus |
title_sort | highly conserved epitope on the spike protein of infectious bronchitis virus |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087072/ https://www.ncbi.nlm.nih.gov/pubmed/8572941 http://dx.doi.org/10.1007/BF01323240 |
work_keys_str_mv | AT wangl ahighlyconservedepitopeonthespikeproteinofinfectiousbronchitisvirus AT parrrl ahighlyconservedepitopeonthespikeproteinofinfectiousbronchitisvirus AT kingdj ahighlyconservedepitopeonthespikeproteinofinfectiousbronchitisvirus AT collissonew ahighlyconservedepitopeonthespikeproteinofinfectiousbronchitisvirus AT wangl highlyconservedepitopeonthespikeproteinofinfectiousbronchitisvirus AT parrrl highlyconservedepitopeonthespikeproteinofinfectiousbronchitisvirus AT kingdj highlyconservedepitopeonthespikeproteinofinfectiousbronchitisvirus AT collissonew highlyconservedepitopeonthespikeproteinofinfectiousbronchitisvirus |